Gossamer Bio (GOSS) Assets (2018 - 2026)
Gossamer Bio (GOSS) posted quarterly Assets of $128.9 million for Q1 2026, down 54.06% year-over-year from $280.6 million in Q1 2025, and down 25.17% quarter-over-quarter from $172.2 million in Q4 2025.
Gossamer Bio (GOSS) Assets (2018 - 2026) Analysis & Trends
Gossamer Bio's Assets history runs 9 years deep, the most recent figure standing at $128.9 million for Q1 2026.
- In Q1 2026, Assets fell 54.06% year-over-year to $128.9 million; the TTM figure through Mar 2026 stood at $128.9 million (down 54.06% YoY), while the FY2025 annual figure was $172.2 million, down 45.37% from the prior year.
- Assets for Q1 2026 stood at $128.9 million, down from $172.2 million in the prior quarter.
- The five-year high for Assets was $373.4 million in Q2 2024, with the low at $128.9 million in Q1 2026.
- The 5-year median for Assets is $272.4 million (2022), against an average of $266.4 million.
- The sharpest annual moves came in 2024 and 2026: Assets soared 105.48% in 2024, then slumped 54.06% in 2026.
- Gossamer Bio's Assets stood at $272.4 million in 2022, then climbed by 14.49% to $311.9 million in 2023, then rose by 1.08% to $315.3 million in 2024, then sank by 45.37% to $172.2 million in 2025, then slipped by 25.17% to $128.9 million in 2026.
- Business Quant data shows GOSS's Assets at $128.9 million in Q1 2026, $172.2 million in Q4 2025, and $208.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Gossamer Bio | 50.34 Mn | -6.69 Mn | - | 76.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 76.87 Mn |
| Mar 31, 2026 | 128.90 Mn |
| Dec 31, 2025 | 172.25 Mn |
| Sep 30, 2025 | 208.82 Mn |
| Jun 30, 2025 | 240.93 Mn |
| Mar 31, 2025 | 280.59 Mn |
| Dec 31, 2024 | 315.29 Mn |
| Sep 30, 2024 | 350.88 Mn |
| Jun 30, 2024 | 373.45 Mn |
| Mar 31, 2024 | 259.36 Mn |
| Dec 31, 2023 | 311.92 Mn |
| Sep 30, 2023 | 347.93 Mn |
| Jun 30, 2023 | 181.75 Mn |
| Mar 31, 2023 | 219.91 Mn |
| Dec 31, 2022 | 272.45 Mn |
| Sep 30, 2022 | 323.54 Mn |
| Jun 30, 2022 | 245.84 Mn |
| Mar 31, 2022 | 294.68 Mn |
| Dec 31, 2021 | 343.66 Mn |
| Sep 30, 2021 | 387.04 Mn |